iRadimed Corp (NAS:IRMD)

Q2 2025 IRadimed Corp Earnings Call Transcript

Aug 1, 2025 / 03:00 PM GMT

Release Date Price: $66.17 (+13.42%)

Transcript 10-Q8-K

Key Points

Positve

iRadimed Corp (IRMD) reported its 16th consecutive quarter of record revenues, achieving $20.4 million in Q2 2025, a 14% increase over the same period last year.
Gross profit remained strong at 78%, with GAAP diluted earnings per share increasing by 18% from Q2 2024.
The company successfully launched its new 3,870 IV pump system, which received FDA clearance, marking a significant milestone.
Domestic sales increased by 18%, contributing to 89% of total revenue for Q2 2025.
The company raised its full-year 2025 revenue guidance to $80 to $82.5 million, reflecting strong first-half performance.

Negative

International sales decreased by 9% to $2.2 million, indicating challenges in global markets.
Operating expenses increased by 9% due to higher sales and marketing costs, impacting overall profitability.
The transition to a new facility is expected to cause short-lived operational inefficiencies.
The backlog for pump orders is running about 5 to 6 months, which could delay revenue realization.
Anticipated bookings for pumps are expected to be low in Q1 2026 due to the transition to the new pump model.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

IRMD.OQ - IRadimed Corp
Q2 2025 IRadimed Corp Earnings Call
Aug 01, 2025 / 03:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the Eradied Corporation. 2nd quarter of 2025 financial results conference call. Currently all participants are in a listen-only mode, and at the end of the call we will conduct a question and answer session. This call is being recorded today, August 1, 2025, and contains time sensitive, accurate information only today.

Earlier, Eradied released its financial results for the 2nd quarter of 2025. A copy of this press release announcing the company's earnings is available under the heading news on their website at erradied.com. A copy of the press release was also furnished to the Securities and Exchange Commission on Form 8K and can be found at SEC.gov. This call is being broadcast live over the internet on the company's website

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.